Format
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 4

1.

The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis.

Michalsk√° D, Stepan JJ, Basson BR, Pavo I.

J Clin Endocrinol Metab. 2006 Mar;91(3):870-7. Epub 2005 Dec 13.

PMID:
16352692
2.
3.

Efficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis: A Meta-Analysis.

Gu HF, Gu LJ, Wu Y, Zhao XH, Zhang Q, Xu ZR, Yang YM.

Medicine (Baltimore). 2015 Nov;94(44):e1674. doi: 10.1097/MD.0000000000001674. Review.

4.

Comparison of the effects of 12 months of monthly minodronate monotherapy and monthly minodronate combination therapy with vitamin K2 or eldecalcitol in patients with primary osteoporosis.

Ebina K, Noguchi T, Hirao M, Kaneshiro S, Tsukamoto Y, Yoshikawa H.

J Bone Miner Metab. 2016 May;34(3):243-50. doi: 10.1007/s00774-015-0710-2. Epub 2015 Aug 25. Review.

PMID:
26303222
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk